Merck Will Build Beijing R&D Center; Invest $1.5 Billion in China
December 06, 2011 at 04:21 AM EST
Merck announced plans to build an Asia Research & Development headquarters in Beijing, which will be devoted to innovative drug discovery and development. The new initiative is part of a broader $1.5 billion investment in China R&D that Merck will make over the next five years. Merck said the investment has two goals: building its own capabilities and fostering relationships with outside researchers. It expects the center to provide new drugs and vaccines that meet global needs. More details.... Stock Symbol: (NYSE: MRK) Share this with colleagues: